Author

N. Liebers

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cell type annotation· 3 Research Focus:clustering· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Assay:scRNA-seq· 2 Assay:spatial transcriptomics· 2

Frequent Co-Authors

M. Knoll· 4 shared T. Roider· 4 shared C. Mueller-Tidow· 3 shared F. Czernilofsky· 3 shared P.-M. Bruch· 3 shared S. Dietrich· 3 shared W. Huber· 3 shared C. Kolb· 2 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

M. Knoll

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cancer BiologyNature Cell BiologyPeer-reviewedMar 1, 2024

Multimodal and spatially resolved profiling identifies distinct patterns of T-cell infiltration in nodal B-cell lymphoma entities

T. Roider, M. A. Baertsch, D. Fitzgerald…·S. Dietrich

DOI 10.1038/s41556-024-01358-2

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 6, 2023

A single-cell multi-omic and spatial atlas of B cell lymphomas reveals differentiation drives intratumor heterogeneity

D. Fitzgerald, T. Roider, M. A. Baertsch…·W. Huber

This study reveals that cellular differentiation drives intratumor heterogeneity in B-cell lymphomas, with distinct maturation states associated with different survival outcomes.

DOI 10.1101/2023.11.06.565756

𝕏 PostBluesky

Cancer BiologybioRxivMar 1, 2022

Proteogenomics refines the molecular classification of chronic lymphocytic leukemia

S. A. Herbst, M. Vesterlund, A. J. Helmboldt…·Hu

The paper performs a proteogenomic analysis of chronic lymphocytic leukemia, identifies a new poor-prognosis subgroup (ASB-CLL) through proteomic profiling, and links it to clinical outcomes.

DOI 10.1038/s41467-022-33385-8

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivFeb 18, 2022

Comparing the value of mono- versus coculture for high-throughput compound screening in hematological malignancies

S. A. Herbst, V. Kim, T. Roider…·S. Dietrich

This study compares monoculture and stromal coculture for drug screening in hematological malignancies, finding that coculture reduces drug efficacy for many compounds but increases it for JAK inhibitors.

DOI 10.1182/bloodadvances.2022009652

humanproteomics

𝕏 PostBluesky